Synthesis and evaluation of amyloid beta peptide/Ruthenium III-based complex drugs as drug delivery and anticancer activity

Rethinam Senthil

Open source

DOI
10.1016/j.toxrep.2024.101778
Published
2024-12
Container
Toxicology Reports
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.toxrep.2024.101778,
  title = {Synthesis and evaluation of amyloid beta peptide/Ruthenium III-based complex drugs as drug delivery and anticancer activity},
  author = {Rethinam Senthil},
  year = {2024},
  journal = {Toxicology Reports},
  doi = {10.1016/j.toxrep.2024.101778},
  url = {https://doi.org/10.1016/j.toxrep.2024.101778}
}

RIS

TY  - JOUR
TI  - Synthesis and evaluation of amyloid beta peptide/Ruthenium III-based complex drugs as drug delivery and anticancer activity
AU  - Rethinam Senthil
PY  - 2024
JO  - Toxicology Reports
DO  - 10.1016/j.toxrep.2024.101778
UR  - https://doi.org/10.1016/j.toxrep.2024.101778
ER  - 

APA

Senthil, R. (2024). Synthesis and evaluation of amyloid beta peptide/Ruthenium III-based complex drugs as drug delivery and anticancer activity. Toxicology Reports. https://doi.org/10.1016/j.toxrep.2024.101778

Source records